首页> 外文期刊>The journal of obstetrics and gynaecology research >Comparison between laparoscopic and abdominal radical hysterectomy for cervical adenosquamous carcinoma at stage IA2 to IIA2: A multicenter retrospective study
【24h】

Comparison between laparoscopic and abdominal radical hysterectomy for cervical adenosquamous carcinoma at stage IA2 to IIA2: A multicenter retrospective study

机译:腹腔镜和腹部根治性子宫切除术治疗 IA2 至 IIA2 期宫颈腺鳞癌的比较:一项多中心回顾性研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Objective: We aimed to compare the 5-year oncological outcomes of laparoscopic/abdominal radical hysterectomy (LRH/ARH) in patients with cervical adenosquamous carcinoma at stage IA2 to IIA2 based on the 2009 or 2018 International Federation of Gynecology and Obstetrics (FIGO) staging criteria.Methods: Based on the clinical diagnosis and treatment of cervical cancer in China (Four C) database, Cox risk regression models were applied to analyze tumor prognosis treated with ARH/LRH in FIGO 2009 and 2018 IA2-IIA2 patients and stratified findings according to tumor diameter ( 4 cm subgroups). And to avoid bias, propensity score matching (PSM) was also used for the cohort study.Results: Based on FIGO 2009 staging criteria (n = 474), there was no significant difference between the ARH and LRH groups in 5-year disease-free survival (DFS) or overall survival (OS). Lymph node metastasis was a risk factor for 5-year DFS in this stage. After PSM, lymphovascular space invasion (LVSI) was an independent risk factor for 5-year OS in the tumors LE;4 cm subgroup. Based on FIGO2018 staging criteria (n = 322), cervical interstitial infiltration depth was an independent risk factor for 5-year OS in the total population and the tumor diameter LE;4 cm subgroup.Conclusions: Laparoscopic surgery was not a risk factor affecting the oncologic prognosis of adenosquamous carcinoma of the cervix based on either FIGO 2009 or 2018 staging of stage IA2-IIA2. In addition, LRH may be considered for patients with early-stage cervical adenosquamous carcinoma.
机译:目的:根据2009年或2018年国际妇产科联合会(International Federation of Gynecology and Obstetrics, FIGO)分期标准,比较腹腔镜/腹部根治性子宫切除术(LRH/ARH)在IA2-IIA2期宫颈腺鳞癌患者中的5年肿瘤学结局。方法:基于中国宫颈癌临床诊疗(四C)数据库,采用Cox风险回归模型分析FIGO 2009和2018年IA2-IIA2患者ARH/LRH治疗的肿瘤预后,并根据肿瘤直径(4 cm亚组)进行分层。为了避免偏倚,倾向得分匹配(PSM)也被用于队列研究。结果:根据FIGO 2009分期标准(n=474),ARH组和LRH组在5年无病生存期(DFS)和总生存期(OS)方面差异无统计学意义。淋巴结转移是该阶段 5 年 DFS 的危险因素。PSM后,淋巴血管间隙浸润(LVSI)是肿瘤&LE5年OS的独立危险因素;4 cm 亚组。根据FIGO2018分期标准(n=322),颈部间质浸润深度是总人群5年OS的独立危险因素,肿瘤直径≤4 cm 亚组。结论:根据FIGO 2009或2018年IA2-IIA2期分期,腹腔镜手术不是影响宫颈腺鳞癌肿瘤预后的危险因素。此外,对于早期宫颈腺鳞癌患者,可考虑使用 LRH。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号